One of applications of directed evolution is to desensitize an enzyme to an inhibitor. k cat ,1/K M and K I are three dimensions that when multiplied measure an enzyme's intrinsic capacity for catalysis in the presence of an inhibitor. The ideal values for the individual dimensions depend on substrate and inhibitor concentrations under the conditions of the application. When attempting to optimize those values by directed evolution, (k cat /K M )*K I can be an informative parameter for evaluating libraries of variants, but throughput is limited. We describe a manipulation of the MichaelisMenten equation for competitive inhibition that isolates (k cat /K M )*K I on one side of the equation. If velocity is measured at constant enzyme and substrate concentrations with two different inhibitor concentrations (one of which can be 0), the data are sufficient to calculate (k cat /K M )*K I with just two rate measurements. The procedure is validated by correlating values obtained by the rapid method with those obtained by substrate saturation kinetics.
Introduction
Directed evolution is a process for improving an enzyme's fitness for a property defined by a commercial or academic interest, directed by empirical observations of the fitness of variants generated in vitro (Nannemann et al., 2011; Currin et al., 2015; Packer and Liu, 2015; Pavlidis et al., 2016) . In the case where the goal is to desensitize the enzyme to an inhibitor, the improvement will be made through elevating the value of K I , the dissociation constant of the enzymeinhibitor complex, as shown in Scheme 1. The equilibrium expression for enzyme, inhibitor and the EI complex re-arranges to the form [E]/[EI] = [KI] [I] . Thus, the larger the K I , the higher is the [E] available for catalysis. must be used. The parameter (k cat /K M )*K I combines an expression of catalytic efficiency (k cat /K M ) with one of affinity for inhibitor compared to substrate (K I /K M ). Improved (k cat /K M )*K I can be attained by increased k cat , decreased K M increased K I or any combination. As inspection of the Michaelis-Menten equation for competitive inhibition shows, increasing k cat is always more effective than reducing K M for increasing the velocity of the inhibited reaction (v i Increasing K I is effective until it reaches the approximate inhibitor concentration, after which further increases will proportionately increase (k cat /K M )*K I , but can only result in a further 2-fold increase in v i . This is shown graphically in Fig. 1 .
The most valuable property of the optimal enzyme is catalytic performance under the conditions of the application. Therefore, the most direct evaluation of a library of variants is to measure reaction velocity under those conditions of substrate and inhibitor concentration, pH and ionic strength, if known. The rate obtained will be described by Equation 1. However, using a single criterion for advancement risks becoming locked into a sequence context that leads to a performance peak that is separated from a higher potential maximum (Packer and Liu, 2015) . One can keep multiple route options open by including another fitness parameter, (k cat /K M )*K I , that can capture variants that are outstanding in one or two of the individual parameters. Consider for example a variant whose v i under application conditions is on par with the current fittest variants, but whose K I lies at the high end of the x-axis in Fig. 1b . That variant will be captured in a screen for (k cat /K M )*K I . Further mutagenesis that reduces K M (beneficial) may also reduce K I (detrimental), because competitive inhibitors often share a binding site with competing substrates. However, if K I is at the high end of the X-axis in Fig. 1B , the detrimental effect on v i of reducing K I is minor while the beneficial effect of a proportional reduction in K M is significant (Fig. 1C) . Thus, (k cat /K M )*K I can be a useful adjunct to measuring v i under application conditions for guiding directed evolution for insensitivity to an inhibitor. Directed evolution often requires dozens of mutations to attain the desired fitness (Siehl et al., 2007 (Siehl et al., , 2014 Currin et al., 2015) . Gene shuffling as described by Stemmer and subsequent elaborations is an efficient method for identifying useful amino acid diversity and generating combinatorial libraries (Stemmer, 1994; Zhang et al., 1997; Crameri et al., 1998 Crameri et al., , 2002 Ness et al., 2002; Wong et al., 2007; Fox and Huisman, 2008 (Boocock and Coggins, 1983; Schonbrunn et al., 2001) . The enzyme catalyzes the transfer of a carboxyvinyl group from PEP to shikimate-3-phosphate (S3P, Fig. 2 ).
Materials and Methods
Source of reagents, enzyme and variants S3P was produced by cultures of Klebsiella pneumonia aroA-(ATCC 25 597) as described (Weiss et al., 1953) and purified by anion exchange chromatography with Dowex 1, eluted with ammonium bicarbonate at pH 7.3. 2-Amino-6-mercapto-7-methylpurine ribonucleoside (MESG) was from Setareh Biotech, Eugene Oregon. All other reagents were from Sigma-Aldrich. The amino acid sequence of mature Zea mays EPSPS was obtained from GenBank entry CAA44974.1. A nucleotide sequence was created to add an N-terminal methionine and to optimize codon usage for expression in Escherichia coli. The synthesized gene was cloned into an expression vector that provides a T7 promoter driving expression of the protein and a 10× N-terminal histidine tag. Variants selected for this study include native maize EPSPS and variants generated by a gene shuffling cascade described elsewhere (US-PCT Application 62/ 234 818). CP4, the EPSPS derived from Agrobacterium sp. strain CP4 (Padgette et al., 1995) , was accessed by gene synthesis. The proteins were expressed in E. coli BL21(DE3) and purified by Ni-NTA resin (Qiagen). Protein concentration was determined by absorbance at Enzyme assay procedure and data analysis EPSPS activity was determined by coupling the release of phosphate (see Fig. 2 ) to reaction with MESG, catalyzed by purine-nucleoside phosphorylase (Webb, 1992) . The absorbance change that occurs was monitored continuously at 360 nm, where the extinction is 11
, with a Spectramax plate reader (Molecular Devices). To determine kinetic parameters in the conventional way, PEP was present at seven concentrations (the eighth being the blank, containing no substrate) ranging from 15 to 800 µM and the unvaried substrate S3P was present at the saturating concentration of 200 µM. Five microliters of 60-fold concentrated stock solutions of PEP were placed in the wells of the 96-well assay plate and reactions were started with the addition of a mixture containing 25 mM Hepes, pH 7, 100 mM KCl, 5% (v/v) ethylene glycol, 0.2 mM MESG, 1 unit/ml purine-nucleoside phosphorylase (Sigma N8264), 200 µM S3P and EPSPS. The enzyme concentration was adjusted so as to generate sufficient signal without exceeding the limit for linear initial reaction rates. The same procedure was repeated with two or three concentrations of Glyph and the data were processed by non-linear regression analysis with GraphPad Prism (graphpad.com) and globally fitted to the Michaelis-Menten equation for competitive inhibition.
For the novel method, the identical assay conditions were used. The PEP concentration was set at 30 µM, which is close to the K m of wild-type EPSPS, while S3P was present at 200 µM. The concentration of EPSPS was fixed at 0.07 µM. Reactions were performed in triplicate, with or without 1 mM Glyph as inhibitor. Values for v 0 and v i were entered into Equation 3, yielding (k cat /K M )*K I .
Results

Rationale and derivation of the equation
In Equation 1, the term (k cat /K M )*K I cannot be isolated due to the presence of the terms K M and [S] in the denominator. However, if two rate measurements are made at different inhibitor concentrations, those terms can be eliminated by subtraction and (k cat /K M )*K i isolated, as follows: Table SI we performed rate measurement with and without inhibitor and used Equation 3. To validate that the rapid method yields an accurate estimation of (k cat /K M )*K I , we compared the results with those obtained by full substrate saturation analysis. The data were obtained for native and shuffled variants of maize 5-enolpyruvylshikimate-3-phosphate (EPSP) synthase. To establish a correlation between actual and surrogate (k cat /K M )*K i , we selected a panel of variants exhibiting a wide range of individual parameters, as determined by substrate saturation, for analysis by the rapid method. Native maize and EPSPS derived from Agrobacterium sp. strain CP4 (Padgette et al., 1995) formed the low and high end of the range. Values in between were supplied by single mutants of both native and Zm-H6 EPSPS. Zm-H6 EPSPS was generated by DNA shuffling and has 15 mutations relative to the native maize enzyme (US-PCT Application 62/ 234 818, Seq ID #5).
The kinetic parameters of the variants spanned a range of 39-fold for k cat , 37-fold for K M , 10 000-fold for K I and 9000-fold for (k cat /K M )*K I . All parameters obtained by both methods are shown in Supplementary Table SI. Linear regression of the values for (k cat / K M )*K I determined by substrate saturation analysis and the rapid method shows an excellent correlation throughout the range of values (Fig. 3) . Fig. 2 The reaction catalyzed by EPSPS. To depict a hypothesis that explains the inhibition by Glyph, PEP is shown as the putative oxocarbenium ion, thought to be generated during the enzyme-catalyzed reaction (Schonbrunn et al., 2001; Eschenburg et al., 2003) .
Discussion
The advantage of the novel method is that with two rate measurements, a lumped parameter ((k cat /K M )*K I ) is generated that captures the kinetic properties essential for catalysis in the presence of inhibitor. More importantly, given an appropriate assay the two reactions could be performed with automated liquid handling, enabling evaluation of hundreds of variants. Ideally, those measurements would accompany a rate measurement at the conditions of the application using the same automated assay.
When used to compare performance of an enzyme with two different substrates, k cat /K M was referred to as the specificity constant (Fersht, 1999) . When comparing variants of an enzyme with the same substrate, k cat /K M captures the net advantage of effects on either parameter and hence has been termed performance constant (Koshland, 2002) . As the second order rate constant for the rate of product formation (when [S] is low relative to
[S]), k cat /K M was termed catalytic efficiency, which when expressed as a function of the rate of the non-catalyzed reaction yielded catalytic proficiency, a parameter that enabled comparison of catalytic efficiency while taking into account the difficulty of the reactions catalyzed (Miller and Wolfenden, 2002) . Recently, k cat /K M was used to compare the catalytic efficiency of a very large number of enzymes to identify evolutionary and physicochemical trends that might account for the range of values seen (Bar-Even et al., 2011) . However, in the context of directed evolution, its use to evaluate enzyme variants for application in a bioreactor or transformed organism can be misleading, mainly because the reaction rate in the application condition is proportional to k cat /K M only when [S] ≪ K M (Eisenthal et al., 2007; Carrillo et al., 2010) . More rigorous formalisms for this purpose, such as efficiency function (Ceccarelli et al., 2008) and catalytic effectiveness (Fox and Clay, 2009) , have been introduced. While the term k cat /K M can be misleading as a comparator, in the early stage of a project where enzyme fitness is poor, K M is often very high relative to the anticipated [S].
Consequently, improvement in either k cat or K M will improve v 0 under application conditions. When inhibition is involved, multiplying k cat /K M by K I additionally captures the magnitude of the inhibitor's dissociation constant. When throughput is a concern, the ability to determine (k cat / K M )*K I with just two rate measurements may warrant its inclusion in a screening cascade. The first steps would be to measure the rate at application conditions and determine (k cat /K M )*K I by the rapid method. Next, the values for (k cat /K M )*K I of the entire lot are compared with those of the best variants as determined by rate at application conditions. If values for (k cat /K M )*K I stand out over those possessed by the best variants under application conditions, it indicates that exceptional individual parameters are present within the population and that further optimization is possible. Any association between outstanding individual parameters and specific mutations may suggest strategies through which the best individual parameters can be captured in one enzyme. Thus, beneficial mutations that could contribute to improved performance in later rounds of shuffling could be missed when relying on rate at application conditions as the sole screening criterion. This is illustrated by hypothetical data (Table I ). Variant A is better than Variant B in terms of catalytic performance under the application condition (v i ), even though Variant B has much greater (k cat /K M )*K I , due solely to its 17.5-fold higher K I . As explained above (Introduction), values of K I above the [I] have a diminishing effect on v i , reaching at most 2-fold. However, this property could potentially be exchanged for a lower K M (Variant C) or higher k cat (Variant D) in later rounds of shuffling to eventually obtain a variant having better performance under application conditions than any of its parents.
There are several practical considerations for accurately estimating (k cat /K M *K I with the rapid method. (i) An enzyme concentration must be found that yields linear initial reaction rates both with and without inhibitor. (ii) The inhibitor concentration must be adjusted so as to obtain a degree of inhibition that minimally amplifies the error in the term v 0 −v i in Equation 3. If inhibition is too little, v 0 −v i will be small, and the error in the multiplier v i × v 0 /(v 0 −v i ) will be large. We set 50% inhibition as our target. (iii) Substrate concentration should be set at the approximate K M of the parental variant(s), subject to the sensitivity of the assay. High substrate concentration obscures sensitivity to the inhibitor and reduces stringency for capturing improvements in K M . However, to meet the requirements for high throughput, there is minimal opportunity for customizing enzyme and inhibitor concentrations. Supplementary Table SI shows that the conditions selected, 0.07 µM enzyme and 1 mM Glyph, were inappropriate for accurate analysis of some of the variants. We repeated the rapid method for those and obtained data that correlated better with data obtained by substrate saturation analysis. For screening purposes, however, that would not have been necessary. Native maize EPSPS, Zm-T103I, Zm-P107L and Zm-P107S would be rejected for advancement based on the first pass analysis, while CP4 would be selected. Conditions should be set so that variants with a pre-determined minimal fitness level are accurately quantified. While the manipulations to isolate k cat /K M *K I were performed on the single substrate form of Equation 1, we applied it to a multisubstrate enzyme by assuming that by supplying the first-binding, non-competitive substrate, S3P, at saturation, the enzyme would behave with single-substrate kinetics. As a practical matter, such treatment is necessary for screening large numbers of variants. It is possible to perform the analogous manipulation that we show for the single-substrate equation with the equation for a random bireactant enzyme, with essentially the same resulting equations as Equations 2 and 3 in supplementary material. Regardless of the details of a given enzyme's kinetic mechanism, finding a practical means of mimicking the single-substrate case should provide an informative screen.
In conclusion, we describe a method by which k cat /K M *K I can be determined with just two rate measurements, and suggest the value of that parameter in a multi-tier screening cascade. Our parameter is of lesser use for optimizing enzymes for industrial bioreactors, where the ability to infuse substrate at high concentration somewhat obviates the need to improve K M or K I , thus focusing optimization primarily on improving k cat . However, for in vivo applications such as fermentation, metabolic engineering in plants and herbicide tolerance, higher substrate concentration may be achieved through engineering, but the levels attained will be limited in many cases. The EPSPS reaction is a case in point. Unlike S3P, which accumulates when Glyph is present, the various metabolic fates of PEP insure that it does not accumulate. Because the inhibition cannot be overcome by increased concentration of the competitive substrate, the improved enzyme must have a higher ratio of K I /K M , which is a component of our parameter.
By analogy with length × width × height yielding volume, the product of k cat × 1/K M × K I is an intrinsic property of the enzyme, independent of the application conditions, that represents the capacity for catalysis in the presence of an inhibitor. Provided that the individual properties can be interconverted through further directed evolution (by no means a given), this intrinsic capacity can be exploited to achieve the optimal distribution of the values of k cat , K M and K I that produce the greatest reaction velocity at application conditions.
Supplementary data
Supplementary data are available at Protein Engineering, Design and Selection online.
